Pyxis Oncology (PYXS) awards director options at $3.12
Rhea-AI Filing Summary
Pyxis Oncology, Inc. (PYXS) reported that director Jakob Dupont received a grant of 46,000 stock options on August 20, 2026. The options have an exercise price of $3.12 per share, expire on August 20, 2036, and will vest in equal monthly installments through October 31, 2026, subject to his continued service. Following this award, he holds 46,000 options directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Dupont Jakob
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F1 | 46,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 46,000 shares (Direct)
Footnotes (1)
- F1. The shares subject to this option will vest in equal monthly installments through October 31, 2026, subject to the reporting person's continued service through the applicable vesting date.
Key Figures
Stock options granted: 46,000 options
Exercise price: $3.12 per share
Option expiration date: August 20, 2036
+2 more
5 metrics
Stock options granted
46,000 options
Grant to director Jakob Dupont on August 20, 2026
Exercise price
$3.12 per share
Exercise price of the granted stock options
Option expiration date
August 20, 2036
Expiration of the granted stock options
Underlying shares
46,000 shares of Common Stock
Shares underlying the stock option grant
Shares following transaction
46,000 options
Total options held by Jakob Dupont after the award
Key Terms
Stock Option (Right to Buy), exercise price, vesting, underlying security
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 3.1200"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shares subject to this option will vest in equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
underlying security financial
"underlying_security_title: Common Stock"
FAQ
What insider transaction did PYXS disclose for Jakob Dupont?
Pyxis Oncology disclosed that director Jakob Dupont received a grant of 46,000 stock options on August 20, 2026, as a compensation-related award, with all options held directly after the transaction.
What is the exercise price of Jakob Dupont’s new PYXS stock options?
The granted stock options have an exercise price of $3.12 per share, allowing Jakob Dupont to buy Pyxis Oncology common stock at that price once the options vest and are exercised.
When do Jakob Dupont’s PYXS stock options vest?
The 46,000 Pyxis Oncology stock options will vest in equal monthly installments through October 31, 2026, contingent on Jakob Dupont’s continued service through each applicable vesting date.
What is the expiration date of the PYXS options granted to Jakob Dupont?
The stock options granted to Jakob Dupont expire on August 20, 2036, giving him up to that date to exercise vested options, subject to the grant’s other terms.
How many PYXS options does Jakob Dupont hold after this grant?
Following this award, Jakob Dupont holds 46,000 stock options for Pyxis Oncology common stock directly, according to the reported post-transaction holdings.
AI-generated analysis. How Rhea-AI works. Not financial advice.
